Forskel mellem versioner af "Oxford–AstraZeneca COVID-19 vaccine"

Oversætter afsnit fra enwiki + reflist
m (Datomærker skabeloner)
(Oversætter afsnit fra enwiki + reflist)
 
Den 30. december 2020 blev vaccinen første gang godkendt til brug i det britiske vaccinationsprogram, og den første vaccination uden for et forsøg blev givet den 4. januar 2021. Vaccinen er siden blevet godkendt af flere lægemiddelagenturer verden over, såsom Det Europæiske Lægemiddelagentur (EMA) og den australske Therapeutic Goods Administration, og den blev godkendt til en liste over nødanvendelse af Verdenssundhedsorganisationen (WHO) Nogle lande har begrænset brugen af vaccinen til ældre mennesker med større risiko for alvorlig COVID-19-sygdom på grund af bekymring over de meget sjældne bivirkninger ved vaccinen hos yngre personer.
 
== Anvendelse ==
=== Godkendelser ===
Storbritannien blev det første land til at udsende en midlertidig nødgodkendelse af Oxford–AstraZeneca-vaccinen idet det britiske [[Medicines and Healthcare products Regulatory Agency]] (MHRA) påbegyndte en undersøgelse af effektivitet og sikkerhedsdata 27. november 2020,<ref>{{cite web|date=27 October 2020|title=Government asks regulator to approve supply of Oxford/AstraZeneca vaccine|url=https://www.gov.uk/government/news/government-asks-regulator-to-approve-supply-of-oxfordastrazeneca-vaccine|access-date=28 November 2020|publisher=Government of the United Kingdom}}</ref> fulgt af en godkendelse 30. december 2020, og blev dermed den anden vaccine godkendt til brug i [[Storbritanniens COVID-19-vaccinationsprogram|landets nationale vaccinationsprogram]].<ref>{{cite web |title=Oxford University/AstraZeneca vaccine authorised by UK medicines regulator |url=https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator |publisher=Government of the United Kingdom |access-date=30 December 2020 |date=30 December 2020}}</ref> BBC rapporterede om at den første person, der modtog vaccinen udenfor kliniske tests, blev vaccineret 4. januar 2021.<ref name="Oxford first vac" />
 
Det [[Europæiske Lægemiddelagentur]] (''European Medicines Agency'' eller blot EMA) påbegyndte en undersøgelse af vaccinen 12. januar 2021, og udtalte i en pressemeddelelse at agenturet kunne udsende en godkendelse 29. januar, hvorefter [[EU-Kommissionen]] kunne beslutte sig for betinget markedsføringsautorisering indenfor få dage.<ref name="EMA application">{{cite news|date=12 January 2021|title=EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca|website=[[Europæiske Lægemiddelagentur]] (EMA)|url=https://www.ema.europa.eu/en/news/ema-receives-application-conditional-marketing-authorisation-covid-19-vaccine-astrazeneca|access-date=12 January 2021}}</ref> 29. januar 2021 anberfalede EMA at give en betinget markedsføringsautorisering for AZD1222 for personer på 18 år og op,<ref name="COVID-19 Vaccine AstraZeneca EPAR" /><ref name="EMA recommendation">{{cite press release | title=EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU | website=[[Europæiske Lægemiddelagentur]] (EMA) | date=29 January 2021 | url=https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu | access-date=29 January 2021}}</ref> og anbefalingen blev accepteret af EU-Kommissionen samme dag.<ref name="EU PR 20210129" /><ref name="EU UR info">{{cite web | title=COVID-19 Vaccine AstraZeneca | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1529.htm | access-date=18 February 2021}}</ref> Den ungarske regulator havde allerede inden EU-godkendelsesproceduren valgt at godkende vaccinen til brug i Ungarn.<ref name="hungary">{{cite web|url=https://hungarytoday.hu/oxford-astrazeneca-vaccine-hungary/|title=Everything You Need to Know About the Oxford-AstraZeneca Vaccine|date=23 January 2021}}</ref>
 
30. januar 2021 godkendte [[Vietnams sundhedsministerium]] AstraZeneca-vaccinen til anvendelse, og den blev dermed den første godkendte vaccine i [[Vietnam]],<ref>{{cite web|last=Nikkei staff writers|title=Coronavirus: Week of Jan.&nbsp;24 to Jan.&nbsp;30, Vietnam approves AstraZeneca vaccine|url=https://asia.nikkei.com/Spotlight/Coronavirus/Coronavirus-Free-to-read/Coronavirus-Week-of-Jan.-24-to-Jan.-30-Vietnam-approves-AstraZeneca-vaccine|website=Nikkei Asia}}</ref> ligesom den 10. februar 2021 blev den første godkendte vaccine i [[Sydkorea]].<ref>{{cite news | vauthors = Kim HJ |date=10 February 2021|title=S. Korea approves AstraZeneca's COVID-19 vaccine for all adults|url=https://en.yna.co.kr/view/AEN20210210006351320|access-date=10 February 2021|publisher=Yonhap News Agency}}</ref><ref>{{cite news | vauthors = Maresca T |date=10 February 2021|title=South Korea approves AstraZeneca COVID-19 vaccine|url=https://www.upi.com/Top_News/World-News/2021/02/10/South-Korea-approves-AstraZeneca-COVID-19-vaccine/4231612945438/|access-date=10 February 2021|publisher=United Press International}}</ref> Vaccinen er derudover blevet godkendt til nødanvendelse i en andre række ikke-EU-lande, heriblandt Argentina,<ref>{{cite news | vauthors = Laing A |title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine -AstraZeneca |url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P |work=Reuters |date=30 December 2020 }}</ref> Bangladesh,<ref>{{cite news |title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use |url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381 |access-date=7 January 2021 |work=The Daily Star |date=4 January 2021 }}</ref> Brasilien,<ref>{{cite web | vauthors = Sabóia G, Mazieiro G, de Andrade H, Adorno L |title=Anvisa aprova uso emergencial das vacinas CoronaVac e AstraZeneca no Brasil|trans-title=Anvisa approves emergency use of the CoronaVac and AstraZeneca vaccines in Brazil|url=https://noticias.uol.com.br/saude/ultimas-noticias/redacao/2021/01/17/anvisa-aprova-pedido-de-vacina-do-butantan-e-da-fiocruz.htm|work=[[Universo Online|UOL]]|language=pt|date=17 January 2021|access-date=17 January 2021}}</ref> Den Dominikanske Republik,<ref name="la-republica-dominicana">{{cite news |title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19 |trans-title=The Dominican Republic approves the AstraZeneca vaccine against covid-19 |url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079 |work=Agencia EFE |date=31 December 2020 |language=es}}</ref> El Salvador,<ref>{{cite news |title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine |url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ |work=Reuters |date=30 December 2020 }}</ref> Indien,<ref>{{cite news | vauthors = Gaurav K |title=Govt's expert panel approves AstraZeneca/Oxford Covid-19 vaccine for emergency use |url=https://www.hindustantimes.com/india-news/india-s-drug-regulator-approves-astrazeneca-oxford-vaccine-sources/story-qtnJQQTBI5vR6QGrXdoBzN.html |work=Hindustan Times |date=1 January 2021 }}</ref><ref>{{cite news | vauthors = Prusty N, Jamkhandikar S |title=India drug regulator approves AstraZeneca COVID vaccine, country's first – sources |url=https://in.reuters.com/article/health-coronavirus-india-vaccine-idINKBN296290 |work=Reuters |date=1 January 2021 }}</ref> Malaysia,<ref>{{cite web|url=https://codeblue.galencentre.org/2021/03/02/malaysias-npra-approves-astrazeneca-sinovac-covid-19-vaccines/|title=Malaysia's NPRA Approves AstraZeneca, Sinovac Covid-19 Vaccines|publisher=CodeBlue|date=2 March 2021|access-date=2 March 2021}}</ref> Mexico,<ref>{{cite news | author = Comisión Federal para la Protección contra Riesgos Sanitarios |title=Autorización Para Uso De Emergencia A Vacuna AstraZeneca COVID-19 |url=https://www.gob.mx/cofepris/articulos/autorizacion-para-uso-de-emergencia-a-vacuna-astrazeneca-covid-19 | trans-title=Authorization For Emergency Use Of AstraZeneca Covid-19 Vaccine |access-date=7 January 2021 |work=gob.mx |language=es}}</ref> Nepal,<ref>{{cite news | title=Nepal approves AstraZeneca COVID vaccine for emergency use – government statement |url=https://www.reuters.com/article/health-coronavirus-nepal/nepal-approves-astrazeneca-covid-vaccine-for-emergency-use-government-statement-idUSKBN29K140 |work=Reuters |date=15 January 2021 }}</ref> Pakistan,<ref>{{cite news| vauthors = Shahzad A |date=16 January 2021|title=Pakistan approves AstraZeneca COVID-19 vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-astrazene-idUKKBN29L0DO|access-date=16 January 2021}}</ref> Filippinerne,<ref name="Reuters">{{cite news |date=28 January 2021 |title=Philippine regulator approves emergency use of AstraZeneca vaccine |work=Reuters |url=https://www.reuters.com/article/us-health-coronavirus-philippines-vaccin-idUSKBN29X0CY |access-date=28 January 2021}}</ref> Sri Lanka,<ref name="apnews.com">{{cite web|date=22 January 2021|title=Sri Lanka approves vaccine amid warnings of virus spread|url=https://apnews.com/article/sri-lanka-coronavirus-pandemic-340488c48ab372050825e70e057dd294|access-date=22 January 2021|website=AP NEWS}}</ref> Taiwan,<ref>{{cite web|title=Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine|url=https://www.msn.com/en-xl/news/newsworld/taiwan-grants-emergency-authorisation-for-astrazeneca-covid-19-vaccine/ar-BB1dQvEk|access-date=22 February 2021|publisher=MSN}}</ref> Australien<ref name="ChAdOx1-S AU PI" /><ref name="AU TGA decision" /> og Canada.<ref>{{cite web|last=Canada|first=Health|title=COVID-19 vaccines and treatments portal: AstraZeneca COVID-19 Vaccine (ChAdOx1-S [recombinant])|url=https://covid-vaccine.canada.ca/astrazeneca-covid-19-vaccine/product-details|access-date=26 February 2021|website=Health Canada}}</ref>
 
10. februar 2021 udsendte [[Verdenssundhedsorganisationen]] (WHO) en midlertidig vejledning og anbefalede AstraZeneca-vaccinen for alle voksne, efter organisationens [[Strategic Advisory Group of Experts]] også havde vurderet tilfælde hvor der var flere varianter til stede, og vurderede at der ikke var nogen grund til ikke at anbefale den.<ref name="RTÉ-20210210">{{cite news|title=AstraZeneca-Oxford vaccine can be used for people aged over 65 – WHO|date=10 February 2021|url=https://www.rte.ie/news/coronavirus/2021/0210/1196328-coronavirus-astrazeneca-vaccine-who/|access-date=12 February 2021|publisher=[[RTÉ News and Current Affairs]]}}</ref>
 
== Se også ==
* [[RNA-vaccine]]
* [[Vaccination]]
 
== Henvisninger ==
{{reflist}}
 
== Eksterne henvisninger ==